½ÃÀ庸°í¼­
»óǰÄÚµå
1392067

¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : À¯Çüº°, ´ëµ¿¸ÆÆÇ À¯Çüº°, ÁßÁõµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Aortic Stenosis Market, By Type, By Aortic Valve Types (Mechanical Aortic Valves and Bioprosthetic Aortic Valves), By Severity, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå ±Ô¸ð´Â 2023³â 83¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2030³â¿¡´Â 167¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.5%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ´ë»ó ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â 2023³â ½ÃÀå ±Ô¸ð 83¾ï 3,000¸¸ ´Þ·¯
¾÷Àû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023³â-2030³â
¿¹Ãø ±â°£ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.50% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 167¾ï 7,000¸¸ ´Þ·¯
±×¸² 1. ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Aortic Stenosis Market-IMG1

´ëµ¿¸Æ ÇùÂøÁõÀº Á½ɽǰú ´ëµ¿¸ÆÀ» ºÐ¸®ÇÏ´Â ´ëµ¿¸Æ ÆÇ¸· °³±¸ºÎÀÇ ÇùÂøÀÔ´Ï´Ù. ½ÉÀå¿¡¼­ ÁÖµ¿¸Æ(´ëµ¿¸Æ)À¸·ÎÀÇ Ç÷·ù¸¦ ¾ïÁ¦ÇÏ¿© ½ÉÀåÀÇ ÁÖÆßÇÁ½ÇÀÇ ¼öÃึ´Ù ½Åü·Î ¼ÛÃâµÇ´Â Ç÷¾×·®À» °¨¼Ò½Ãŵ´Ï´Ù. ´ëµ¿¸Æ ÇùÂøÁõÀÇ ÁøÇàÀº ¼ö³â¿¡ °ÉÃÄ ÃµÃµÈ÷ ¹ß»ýÇϸç Ãʱ⠴ܰ迡¼­´Â ¹«Áõ»óÀÌÁö¸¸ ½É°¢ÇØÁü¿¡ µû¶ó Áõ»óÀÌ ³ªÅ¸³³´Ï´Ù. ¹ëºê ÀÔ±¸°¡ ´õ Á¼¾ÆÁö¸é Á¦ÇÑµÈ ¹ëºê ÀÔ±¸¿¡¼­ ÃæºÐÇÑ Ç÷¾×À» º¸³»±â À§ÇØ ½ÉÀåÀÌ ´õ °­ÇÏ°Ô ÀÛµ¿ÇؾßÇÏ¸ç ½ÉÀå¿¡ ¿©ºÐÀÇ ºÎ´ãÀÌ °É¸³´Ï´Ù. ÀÌ ¶§¹®¿¡ Ä¡·á¸¦ ÇÏÁö ¾ÊÀ¸¸é °á±¹ ½É±ÙÀÌ ¾àÇØÁ® ¼Õ»óµÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

°íÇ÷¾Ð, ºñ¸¸, ´ç´¢º´°ú °°Àº À§Çè ¿äÀÎÀÇ À¯º´·ü Áõ°¡´Â ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ´ëµ¿¸Æ ÇùÂøÁõÀÇ ÀϹÝÀûÀÎ ¿øÀÎÀº ³ëÈ­, ´ëµ¿¸Æ ÆÇ¸·¿¡ Ä®½·ÀÌ Ä§ÂøÇÏ¿© µüµüÇØÁö´Â °Í, ·ù¸¶Æ¼½º ¿­, ´ëµ¿¸Æ ÆÇ¸·ÀÇ ¼±Ãµ±âÇü µîÀÌ ÀÖ½À´Ï´Ù. °í·ÉÈ­, ±â¼ú Áøº¸ ¹× ÀÎÁöµµ Çâ»óÀº ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡, ÀÇ·á ÁöÃâ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ä«Å×ÅÍ ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú(TAVR)ÀÇ È®´ë, ½ÅÈï ±¹°¡ ½ÃÀå¿¡¼­ÀÇ Ä¡·á ¹× ½Å¾à °³Ã´, ¸ÂÃãÇü ÀÇ·á, ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀº ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå¿¡ ¼ºÀå ±âȸ¸¦ °¡Á®¿É´Ï´Ù. ¿¹»óµË´Ï´Ù.

±×·¯³ª °í°¡ÀÇ Ä¡·áºñ, Á¦ÇÑÀûÀÎ »óȯ Á¤Ã¥, À̿밡´É¼º ¹× ÀÎÁöµµ À庮, ÀÓ»óÀû ¹× ¼ö¼úÀû ÇÕº´ÁõÀº ¿¹Ãø ±â°£ µ¿¾È ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2023³â-2030³â) ½ÃÀå ±Ô¸ð¿Í º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·Ä¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã¿Í ½ÂÀÎ, ½ÃÀ嵿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀïÀü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­¸¦ ÅëÇØ ÀλçÀÌÆ®À» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, ÆÇ¸ÅÀÚ, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • °í·É Àα¸
    • °í¾×ÀÇ Ä¡·áºñ
    • °æ Ä«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ¼ú(TAVR) È®´ë
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À

Á¦4Àå ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : À¯Çüº°(2018³â-2030³â)

  • ¼Ò°³
  • ¼±Ãµ¼º ´ëµ¿¸Æ ÇùÂøÁõ
  • ÈÄõ¼º ´ëµ¿¸Æ ÇùÂøÁõ

Á¦6Àå ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ´ëµ¿¸ÆÆÇ À¯Çüº°(2018³â-2030³â)

  • ¼Ò°³
  • ±â°è½Ä ´ëµ¿¸ÆÆÇ
  • »ýü Àΰø(Á¶Á÷) ´ëµ¿¸ÆÆÇ

Á¦7Àå ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ÁßÁõµµº°(2018³â-2030³â)

  • ¼Ò°³
  • °æ¹ÌÇÑ ´ëµ¿¸Æ ÇùÂøÁõ
  • ÁߵÀÇ ´ëµ¿¸Æ ÇùÂøÁõ
  • ½ÉÇÑ ´ëµ¿¸Æ ÇùÂøÁõ

Á¦8Àå ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2018³â-2030³â)

  • ¼Ò°³
  • º´¿ø
  • Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦9Àå ¼¼°è ´ëµ¿¸Æ ÇùÂøÁõ ½ÃÀå : Áö¿ªº°(2018³â-2030³â)

  • ¼Ò°³
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ·¹ÀÎ ¹× ¹Ì±¹
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • ASEAN ±¹°¡
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc
  • Braile Biomedica
  • JenaValve Technology, Inc
  • Meril Life Sciences Pvt. Ltd
  • Micro Interventional Devices, Inc
  • egnite, Inc.

Á¦11Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
BJH 23.12.21

The Global Aortic Stenosis Market size is expected to reach US$ 16.77 billion by 2030, from US$ 8.33 billion in 2023, at a CAGR of 10.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 8.33 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.50% 2030 Value Projection: US$ 16.77 Bn
Figure 1. Global Aortic Stenosis Market Share (%), By Region, 2023
Aortic Stenosis Market - IMG1

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Global Aortic Stenosis Market Detailed Segmentation:

  • By Type:
    • Congenital Aortic Stenosis
    • Acquired Aortic Stenosis
  • By Aortic Valve Types:
    • Mechanical Aortic Valves
    • Bioprosthetic (Tissue) Aortic Valves
  • By Severity:
    • Mild Aortic Stenosis
    • Moderate Aortic Stenosis
    • Severe Aortic Stenosis
  • By End User:
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profile:
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • Braile Biomedica
    • JenaValve Technology, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Micro Interventional Devices, Inc.
    • gnite, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Aortic Valve Types
    • Market Snapshot, By Severity
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Aging Population
    • High Cost of Treatment
    • Transcatheter Aortic Valve Replacement (TAVR) Expansion
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Pipeline Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Aortic Stenosis Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Aortic Stenosis Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Congenital Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Acquired Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Aortic Stenosis Market, By Aortic Valve Types, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Mechanical Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Bioprosthetic (Tissue) Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Aortic Stenosis Market, By Severity, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Mild Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Moderate Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Severe Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Aortic Stenosis Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Aortic Stenosis Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Lain America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CryoLife, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • JenaValve Technology, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Meril Life Sciences Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Micro Interventional Devices, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • egnite, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦